Optimization of decellularization methods using human small intestinal submucosa for scaffold generation in regenerative medicine
International Journal of Experimental Pathology · 2023
DOI: 10.1111/iep.12492 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Experimental Pathology, 2023. Verfasst von Shumei Mineta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Japan. Hauptthemen laut MEDLINE: Tissue Scaffolds, Tissue Engineering. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Porcine small intestinal submucosa, despite its successful use as a scaffold in regenerative medicine, has innate biomechanical heterogeneity. In this study, we hypothesized that human small intestinal submucosa could be a viable alternative bio‐scaffold. For the first time, we characterize submucosal extraction from human small intestine and examine appropriate decellularization methods. In total, 16 human small intestinal submucosal samples were obtained and decellularized using three reported methods of porcine decellularization: Abraham, Badylak, and Luo. For each method, four specimens were decellularized. The remaining four specimens were designated as non‐decellularized. We measured the amount of residual DNA and growth factors in decellularized human intestinal samples. Additionally, decellularized human small intestinal submucosa was co‐cultured with mouse bone marrow‐derived mesenchymal stem cells to examine mesenchymal stem cell survival and proliferation. The reference value for the amount of residual DNA deemed appropriate in decellularized tissue was established as 50 ng/mg of extracellular matrix dry weight or less. Abraham's method most successfully met this criterion. Measurement of residual growth factors revealed low levels observed in samples decellularized using the Abraham and Badylak methods. Co‐culture of each small intestinal submucosal sample with mouse bone marrow‐derived mesenchymal stem cells confirmed viable cell survival and proliferation in samples derived using protocols by Abraham and Badylak. Abraham's method most successfully met the criteria for efficient tissue decellularization and cell viability and proliferation. Thus, we consider this method most suitable for decellularization of human small intestinal submucosa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Japan.
ORCID-Profile: Shumei Mineta
Zitieren
APA
Mineta, S., Endo, S., & Ueno, T. (2023). Optimization of decellularization methods using human small intestinal submucosa for scaffold generation in regenerative medicine. International Journal of Experimental Pathology. https://doi.org/10.1111/iep.12492
Vancouver
Mineta S, Endo S, Ueno T. Optimization of decellularization methods using human small intestinal submucosa for scaffold generation in regenerative medicine. International Journal of Experimental Pathology. 2023. doi:10.1111/iep.12492
BibTeX
@article{Mineta2023,
author = {Mineta, Shumei and Endo, Shunji and Ueno, Tomio},
title = {Optimization of decellularization methods using human small intestinal submucosa for scaffold generation in regenerative medicine},
journal = {International Journal of Experimental Pathology},
year = {2023},
doi = {10.1111/iep.12492}
}
EUVIMED